1.965
6.43%
-0.135
Handel nachbörslich:
1.965
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.40%
4.443
|
4.339 | 5.111 | 4.502 | 5.694 |
Interest Income/Expense |
-0.32
|
- | - | - | 0.001 |
Depreciation and Amortization |
12.77%
0.053
|
0.047 | 0.049 | 0.048 | 0.047 |
Operating Income/Loss |
2.40%
-4.443
|
-4.339 | -5.111 | -4.502 | -5.694 |
Nonoperating Income/Loss |
0.278
|
- | -0.078 | 0.001 | -0.006 |
Income/Loss From Continuing Operations Before Tax |
0.02%
-4.165
|
-4.166 | -5.189 | -4.501 | -5.70 |
Income/Loss From Continuing Operations After Tax |
0.02%
-4.165
|
-4.166 | -5.189 | -4.501 | -5.70 |
Net Income/Loss
|
0.02%
-4.165
|
-4.166 | -5.189 | -4.501 | -5.70 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.87%
10.15
|
10.06 | 8.143 | - | 8.143 |
Diluted Average Shares |
0.87%
10.15
|
10.06 | -0.956 | - | - |
Basic Earnings Per Share |
0.00%
-0.41
|
-0.41 | -0.64 | -0.54 | -0.70 |
Diluted Earnings Per Share |
0.00%
-0.41
|
-0.41 | -0.62 | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):